Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. A.W.J.M. (Andor) Glaudemans

Research interests

The main research line is “Imaging I3”: Infection, Inflammation, and (tumor)Immunology


  • Musculoskeletal: peripheral osteomyelitis, device-related infections such as prosthetic joint infections, diabetic foot infection, fracture-related infections

  • Cardiovascular: endocarditis, device-related infections such as vascular graft infections, intravascular prosthetic material infections

  • Sepsis/bloodstream infections: bacteremia, specific bacterial infections

  • Fungal infections

  • Infections in children



  • Amyloidosis

  • Sarcoidosis

  • Tuberculosis, HIV/AIDS

  • Atherosclerosis and vasculitis

  • Rejection and PTLD after organ transplantation

  • Inflammatory diseases in children

  • Sports injuries



  • Imaging autoimmune reaction/checkpoints in tumors

  • Imaging of lymphocytes

  • Imaging of macrophages


Societal impact:

  • Development of diagnostic and therapeutic flowcharts in infectious and inflammatory diseases

  • Publication of several Dutch (NFU, NVNG) and European (EANM) guidelines/recommendations

  • Development and implementation of new specific tracers in infectious and inflammatory diseases (IL-2, PD1/PDL1, sorbitol, labelled antibiotics, labelled antifungal drugs)

  • Improvement of existing techniques for infection imaging (new protocols for white blood cell scintigraphy and FDG-PET)

  • Role of nuclear medicine in therapy evaluation of infectious and inflammatory diseases and during/after immunotherapy


Besides this Imaging I3 research line, I also perform some research in the field of oncology (this is also the main differential diagnosis with infectious diseases in PET):

  • Imaging of hormonal receptors (FES-PET, FDHT-PET)

  • Imaging of brain tumors

  • Imaging of apoptosis

  • Imaging lymphomas

Other research tasks:

  • Co-chair research Medical Imaging Center

  • Responsible person for contract research Medical Imaging Center

  • Coordinator of the research line Oncology, Infection and Transplantation

  • Writing publications and grant applications

  • Writing Dutch (NFU, NVNG) and European (EANM) guidelines/recommendations

  • Reviewer of manuscripts

  • Collaboration with many external centers (Netherlands, Europe and worldwide) 

Read more


[15O]H2O PET: Potential or Essential for Molecular Imaging?

[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

[18F]FDG-PET/CT in mechanically ventilated critically ill patients with COVID-19 ARDS and persistent inflammation.

Added Value of Abnormal Lymph Nodes Detected with FDG-PET/CT in Suspected Vascular Graft Infection

Added value of semi-quantitative analysis of [18F]FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device

A high prevalence of Cutibacterium acnes infections in scoliosis revision surgery, a diagnostic and therapeutic dilemma

At the cutting-edge: what's the latest in imaging to diagnose Sjögren's syndrome?

Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?: an early follow-up marker?

Current and Future Use of Long Axial Field-of-View Positron Emission Tomography/Computed Tomography Scanners in Clinical Oncology

Diagnosis and treatment of vascular graft and endograft infections: a structured clinical approach

Read more


Netherlands grants permit to new nuclear reactor for medical isotopes

Hoogleraar: nieuwe reactor Petten helpt om levens te redden

Drie UMCG-onderzoeken krijgen subsidie van KWF

Kopzorgen over een kernreactor: behandeling van anderhalf miljoen kankerpatiënten op het spel

Belang van steun kernreactor Petten

Jaarlijks 129 miljoen staatssteun voor nieuwe kernreactor in Petten, van belang voor kankerpatiënten

Stilliggen reactor Petten treft mogelijk honderden kankerpatiënten

Read more